Triazine formulations with a second active ingredient and surfactant(s)
AssigneeCeva Sante Animale
InventorsANNE-CLAIRE LE MEUR, FLORENCE GUIMBERTEAU
Life of this patent
Estimating the term…
Abstract
The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
Claims4
A method for treating an infectious disease in a non-human animal comprising administering to said animal a composition comprising at least one triazine compound and a further active ingredient, wherein said composition is an aqueous suspension containing one or more surfactant(s) having a Hydrophilic-Lipophilic Balance (HLB) comprised between 1 and 8.
Dependencies are inferred from the claim text.